Comparison of two transarterial chemoembolization regimens in patients with unresectable hepatocellular carcinoma: raltitrexed plus oxaliplatin versus 5-fluorouracil plus oxaliplatin

AIMS: To compare the safety and efficacy of TACE using raltitrexed, oxaliplatin and epirubicin with 5-fluorouracil, oxaliplatin and epirubicin for patients with unresectable hepatocelluar carcinoma. RESULTS: Median overall survival (OS) was 7.4 months in the raltitrexed group [95% confidence interva...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncotarget
Autors principals: Cui, Wei, Fan, Wenzhe, Zhang, Qun, Wen, Jia, Huang, Yonghui, Yang, Jianyong, Li, Jiaping, Wang, Yu
Format: Artigo
Idioma:Inglês
Publicat: Impact Journals LLC 2017
Matèries:
Clinical Research Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5668029/
https://ncbi.nlm.nih.gov/pubmed/29108296
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.16298
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars